Relevant Updates to the Interim Bulk Drug Substances List for 503A Pharmacies 2,4,5,6 For a full list of updates, please download the complete Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act document linked above
Stress Response and Anxiolytic Models: In rodent elevated plus-maze, open-field, and restraint-stress models as well as small human trials, DSIP reduced behavioral signs of anxiety, lowered plasma cortisol/ACTH responses to stress, and normalized stress-induced alterations in catecholamine and serotonin turnover
Bioavailability: Why Most Oral Glutathione Fails Reduced L-glutathione
UV light (including indirect sunlight) cleaves peptide bonds in solution
Are you smothering your people